{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:19:58Z","timestamp":1757618398121,"version":"3.44.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T00:00:00Z","timestamp":1741824000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060538","31900375"],"award-info":[{"award-number":["82060538","31900375"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Wu Jieping Medical Foundation Special Fund for Clinical Research","award":["320.6750.2022-19-56"],"award-info":[{"award-number":["320.6750.2022-19-56"]}]},{"name":"the Key Project of Yunnan Applied Basic Research","award":["202401AS070023"],"award-info":[{"award-number":["202401AS070023"]}]},{"name":"Kunming Medical University Breast Cancer Precision \u2026 Translational Medicine Research Team","award":["2024XKTDYS08"],"award-info":[{"award-number":["2024XKTDYS08"]}]},{"name":"Middle-aged and Young Academic and Technical Leader Reserve Talent Program of Yunnan Province Science and Technology Department","award":["202205AC160008"],"award-info":[{"award-number":["202205AC160008"]}]},{"name":"Chinese Academy of Sciences (\u2018Light of West China\u2019 Program), and the Science and Technology Department of Yunnan Province","award":["202001AT070106"],"award-info":[{"award-number":["202001AT070106"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Screening bioactive compounds from natural sources, including animals and plants, is a valuable strategy for identifying novel anti-tumor agents. \u03b1-Toxin BmK-M9, a key component of scorpion venom, has received limited attention regarding its potential anti-cancer effects and underlying mechanisms in breast cancer. This study investigates the effects and mechanisms of BmK-M9 in breast cancer using in vitro experiments and a nude mouse model. mRNA sequencing was performed to identify affected signaling pathways, while Western blotting and immunohistochemistry were utilized to analyze the Wnt\/\u03b2-catenin signaling pathway. The results demonstrated that BmK-M9 significantly inhibited breast cancer cell invasion and migration in vitro and suppressed tumor growth in vivo. Transcriptomic analysis revealed that BmK-M9 influenced cellular processes related to proliferation, apoptosis, motility, and metabolism. Furthermore, BmK-M9 markedly downregulated \u03b2-catenin expression in the Wnt\/\u03b2-catenin pathway. These findings suggest that BmK-M9 exerts anti-tumor effects in breast cancer by modulating Wnt\/\u03b2-catenin signaling, highlighting its potential as a promising therapeutic candidate.<\/jats:p>","DOI":"10.1007\/s12013-025-01711-8","type":"journal-article","created":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T07:46:22Z","timestamp":1741851982000},"page":"3299-3314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Recombinant \u03b1-Toxin BmK-M9 Inhibits Breast Cancer Progression by Regulating \u03b2-Catenin In Vivo"],"prefix":"10.1007","volume":"83","author":[{"given":"Wenlin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuocen","family":"Cha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saijun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiayi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter Muiruri","family":"Kamau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingjia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dequan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,13]]},"reference":[{"key":"1711_CR1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/ijc.35278","volume":"156","author":"AM Filho","year":"2024","unstructured":"Filho, A. M., Laversanne, M., Ferlay, J., Colombet, M., Pi\u00f1eros, M., Znaor, A., Parkin, D. M., Soerjomataram, I., & Bray, F. (2024). The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. International Journal of Cancer, 156, 1336\u20131346.","journal-title":"International Journal of Cancer"},{"key":"1711_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.117245","volume":"243","author":"L Arzi","year":"2020","unstructured":"Arzi, L., Hoshyar, R., Jafarzadeh, N., Riazi, G., & Sadeghizadeh, M. (2020). Anti-metastatic properties of a potent herbal combination in cell and mice models of triple negative breast cancer. Life Sciences, 243, 117245.","journal-title":"Life Sciences"},{"key":"1711_CR3","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.bbrc.2020.03.050","volume":"526","author":"C Tang","year":"2020","unstructured":"Tang, C., Gong, L., Lvzi, X., Qiu, K., Zhang, Z., & Wan, L. (2020). Echinacoside inhibits breast cancer cells by suppressing the Wnt\/\u03b2-catenin signaling pathway. Biochemical and Biophysical Research Communications, 526, 170\u2013175.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1711_CR4","first-page":"3868","volume":"62","author":"S Somasundaram","year":"2002","unstructured":"Somasundaram, S., Edmund, N. A., Moore, D. T., Small, G. W., Shi, Y. Y., & Orlowski, R. Z. (2002). Dietary curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer. Cancer Research, 62, 3868\u20133875.","journal-title":"Cancer Research"},{"key":"1711_CR5","doi-asserted-by":"publisher","first-page":"3030","DOI":"10.1007\/s00018-006-6315-0","volume":"63","author":"DC Koh","year":"2006","unstructured":"Koh, D. C., Armugam, A., & Jeyaseelan, K. (2006). Snake venom components and their applications in biomedicine. Cellular and Molecular Life Sciences, 63, 3030\u20133041.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"1711_CR6","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1177\/1535370213513991","volume":"239","author":"J Ding","year":"2014","unstructured":"Ding, J., Chua, P. J., Bay, B. H., & Gopalakrishnakone, P. (2014). Scorpion venoms as a potential source of novel cancer therapeutic compounds. Experimental Biology and Medicine, 239, 387\u2013393.","journal-title":"Experimental Biology and Medicine"},{"key":"1711_CR7","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3390\/toxins7020219","volume":"7","author":"Q Du","year":"2015","unstructured":"Du, Q., Hou, X., Wang, L., Zhang, Y., Xi, X., Wang, H., Zhou, M., Duan, J., Wei, M., Chen, T., & Shaw, C. (2015). AaeAP1 and AaeAP2: Novel antimicrobial peptides from the venom of the scorpion, Androctonus aeneas: Structural characterisation, molecular cloning of biosynthetic precursor-encoding cDNAs and engineering of analogues with enhanced antimicrobial and anticancer activities. Toxins, 7, 219\u2013237.","journal-title":"Toxins"},{"key":"1711_CR8","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2174\/1568026616666160930151242","volume":"17","author":"M Primon-Barros","year":"2017","unstructured":"Primon-Barros, M., & Jos\u00e9 Macedo, A. (2017). Animal venom peptides: Potential for new antimicrobial agents. Current Topics in Medicinal Chemistry, 17, 1119\u20131156.","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"1711_CR9","doi-asserted-by":"publisher","DOI":"10.1590\/1678-9199-jvatitd-14-63-18","volume":"25","author":"T Wu","year":"2019","unstructured":"Wu, T., Wang, M., Wu, W., Luo, Q., Jiang, L., Tao, H., & Deng, M. (2019). Spider venom peptides as potential drug candidates due to their anticancer and antinociceptive activities. The Journal of Venomous Animals and Toxins Including Tropical Diseases, 25, e146318.","journal-title":"The Journal of Venomous Animals and Toxins Including Tropical Diseases"},{"key":"1711_CR10","doi-asserted-by":"publisher","first-page":"7857","DOI":"10.1021\/acs.jmedchem.9b00634","volume":"62","author":"P Zhang","year":"2019","unstructured":"Zhang, P., Ma, J., Zhang, Q., Jian, S., Sun, X., Liu, B., Nie, L., Liu, M., Liang, S., Zeng, Y., & Liu, Z. (2019). Monosaccharide analogues of anticancer peptide R-Lycosin-I: Role of monosaccharide conjugation in complexation and the potential of lung cancer targeting and therapy. Journal of Medicinal Chemistry, 62, 7857\u20137873.","journal-title":"Journal of Medicinal Chemistry"},{"key":"1711_CR11","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.3390\/ijerph17062078","volume":"17","author":"MA Medina","year":"2020","unstructured":"Medina, M. A., Oza, G., Sharma, A., Arriaga, L. G., Hern\u00e1ndez Hern\u00e1ndez, J. M., Rotello, V. M., & Ramirez, J. T. (2020). Triple-negative breast cancer: A review of conventional and advanced therapeutic strategies. International Journal of Environmental Research and Public Health, 17, 2078.","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"1711_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.peptides.2017.09.017","volume":"99","author":"F Yang","year":"2018","unstructured":"Yang, F., Liu, S., Zhang, Y., Qin, C., Xu, L., Li, W., Cao, Z., Li, W., & Wu, Y. (2018). Expression of recombinant \u03b1-toxin BmKM9 from scorpion Buthus martensii Karsch and its functional characterization on sodium channels. Peptides, 99, 153\u2013160.","journal-title":"Peptides"},{"key":"1711_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.14","volume":"6","author":"SG Pohl","year":"2017","unstructured":"Pohl, S. G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017). Wnt signaling in triple-negative breast cancer. Oncogenesis, 6, e310.","journal-title":"Oncogenesis"},{"key":"1711_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103597","volume":"28","author":"DK Patel","year":"2023","unstructured":"Patel, D. K., Kesharwani, R., Verma, A., Al-Abbasi, F. A., Anwar, F., & Kumar, V. (2023). Scope of Wnt signaling in the precise diagnosis and treatment of breast cancer. Drug Discovery Today, 28, 103597.","journal-title":"Drug Discovery Today"},{"key":"1711_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1002\/emmm.201201320","volume":"5","author":"P Wend","year":"2013","unstructured":"Wend, P., Runke, S., Wend, K., Anchondo, B., Yesayan, M., Jardon, M., Hardie, N., Loddenkemper, C., Ulasov, I., Lesniak, M. S., Wolsky, R., Bentolila, L. A., Grant, S. G., Elashoff, D., Lehr, S., Latimer, J. J., Bose, S., Sattar, H., Krum, S. A., & Miranda-Carboni, G. A. (2013). WNT10B\/\u03b2-catenin signalling induces HMGA2 and proliferation in metastatic triple-negative breast cancer. EMBO Molecular Medicine, 5, 264\u2013279.","journal-title":"EMBO Molecular Medicine"},{"key":"1711_CR16","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1016\/j.cell.2012.11.024","volume":"151","author":"V Luga","year":"2012","unstructured":"Luga, V., Zhang, L., Viloria-Petit, A. M., Ogunjimi, A. A., Inanlou, M. R., Chiu, E., Buchanan, M., Hosein, A. N., Basik, M., & Wrana, J. L. (2012). Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell, 151, 1542\u20131556.","journal-title":"Cell"},{"key":"1711_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10633","volume":"7","author":"X Wang","year":"2016","unstructured":"Wang, X., Jung, Y. S., Jun, S., Lee, S., Wang, W., Schneider, A., Sun Oh, Y., Lin, S. H., Park, B. J., Chen, J., Keyomarsi, K., & Park, J. I. (2016). PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness. Nature Communications, 7, 10633.","journal-title":"Nature Communications"},{"key":"1711_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/emmm.201303411","volume":"6","author":"M Piva","year":"2014","unstructured":"Piva, M., Domenici, G., Iriondo, O., R\u00e1bano, M., Sim\u00f5es, B. M., Comaills, V., Barredo, I., L\u00f3pez-Ruiz, J. A., Zabalza, I., Kypta, R., & Vivanco, Md. M. (2014). Sox2 promotes tamoxifen resistance in breast cancer cells. EMBO Molecular Medicine, 6, 66\u201379.","journal-title":"EMBO Molecular Medicine"},{"key":"1711_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12964-019-0419-2","volume":"17","author":"S Jiang","year":"2019","unstructured":"Jiang, S., Zhang, M., Zhang, Y., Zhou, W., Zhu, T., Ruan, Q., Chen, H., Fang, J., Zhou, F., Sun, J., & Yang, X. (2019). WNT5B governs the phenotype of basal-like breast cancer by activating WNT signaling. Cell Communication and Signaling: CCS, 17, 109.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"1711_CR20","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.cell.2016.02.025","volume":"165","author":"S Malladi","year":"2016","unstructured":"Malladi, S., Macalinao, D. G., Jin, X., He, L., Basnet, H., Zou, Y., de Stanchina, E., & Massagu\u00e9, J. (2016). Metastatic latency and immune evasion through autocrine inhibition of WNT. Cell, 165, 45\u201360.","journal-title":"Cell"},{"key":"1711_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2022.113161","volume":"417","author":"Q Zhu","year":"2022","unstructured":"Zhu, Q., Wan, N. B., Deng, H. W., Lu, L. L., Zhang, Y., He, X., Liu, H., & He, Y. (2022). SEC14L3 plays a tumor-suppressive role in breast cancer through a Wnt\/\u03b2-catenin-related way. Experimental Cell Research, 417, 113161.","journal-title":"Experimental Cell Research"},{"key":"1711_CR22","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13058-023-01620-9","volume":"25","author":"ZH Chen","year":"2023","unstructured":"Chen, Z. H., Tian, Y., Zhou, G. L., Yue, H. R., Zhou, X. J., Ma, H. Y., Ge, J., Wang, X., Cao, X. C., & Yu, Y. (2023). CMTM7 inhibits breast cancer progression by regulating Wnt\/\u03b2-catenin signaling. Breast Cancer Research : BCR, 25, 22.","journal-title":"Breast Cancer Research : BCR"},{"key":"1711_CR23","doi-asserted-by":"publisher","first-page":"e63865","DOI":"10.1371\/journal.pone.0063865","volume":"8","author":"JK Klint","year":"2013","unstructured":"Klint, J. K., Senff, S., Saez, N. J., Seshadri, R., Lau, H. Y., Bende, N. S., Undheim, E. A., Rash, L. D., Mobli, M., & King, G. F. (2013). Production of recombinant disulfide-rich venom peptides for structural and functional analysis via expression in the periplasm of E. coli. PLoS ONE, 8, e63865.","journal-title":"PLoS ONE"},{"key":"1711_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/4234273","volume":"2020","author":"SA Richard","year":"2020","unstructured":"Richard, S. A., Kampo, S., Sackey, M., Hechavarria, M. E., & Buunaaim, A. D. B. (2020). The pivotal potentials of scorpion buthus martensii karsch-analgesic-antitumor peptide in pain management and cancer. Evidence-Based Complementary and Alternative Medicine : eCAM, 2020, 4234273.","journal-title":"Evidence-Based Complementary and Alternative Medicine : eCAM"},{"key":"1711_CR25","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3389\/fonc.2019.00021","volume":"9","author":"S Kampo","year":"2019","unstructured":"Kampo, S., Ahmmed, B., Zhou, T., Owusu, L., Anabah, T. W., Doudou, N. R., Kuugbee, E. D., Cui, Y., Lu, Z., Yan, Q., & Wen, Q. P. (2019). Scorpion venom analgesic peptide, BmK AGAP inhibits stemness, and epithelial-mesenchymal transition by down-regulating PTX3 in breast cancer. Frontiers in Oncology, 9, 21.","journal-title":"Frontiers in Oncology"},{"key":"1711_CR26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1177\/15353702221090454","volume":"247","author":"FA Kuypers","year":"2022","unstructured":"Kuypers, F. A. (2022). Hyperinflammation, apoptosis, and organ damage. Experimental Biology and Medicine, 247, 1112\u20131123.","journal-title":"Experimental Biology and Medicine"},{"issue":"Suppl","key":"1711_CR27","doi-asserted-by":"publisher","first-page":"S78","DOI":"10.1016\/j.semcancer.2015.03.001","volume":"35","author":"RM Mohammad","year":"2015","unstructured":"Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H. Y., Lin, L. T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., Yang, H., Samadi, A. K., Russo, G. L., Spagnuolo, C., Ray, S. K., Chakrabarti, M., Morre, J. D., Coley, H. M., Honoki, K., & Azmi, A. S. (2015). Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology, 35(Suppl), S78\u2013s103.","journal-title":"Seminars in Cancer Biology"},{"key":"1711_CR28","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/s12094-017-1774-3","volume":"20","author":"C Yang","year":"2018","unstructured":"Yang, C., Zhang, J., Ding, M., Xu, K., Li, L., Mao, L., & Zheng, J. (2018). Ki67 targeted strategies for cancer therapy. Clinical & Translational Oncology, 20, 570\u2013575.","journal-title":"Clinical & Translational Oncology"},{"key":"1711_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/1534735417704949","volume":"17","author":"AK Al-Asmari","year":"2018","unstructured":"Al-Asmari, A. K., Riyasdeen, A., & Islam, M. (2018). Scorpion venom causes upregulation of p53 and downregulation of Bcl-x(L) and BID protein expression by modulating signaling proteins Erk(1\/2) and STAT3, and DNA damage in breast and colorectal cancer cell lines. Integrative Cancer Therapies, 17, 271\u2013281.","journal-title":"Integrative Cancer Therapies"},{"key":"1711_CR30","doi-asserted-by":"publisher","first-page":"708","DOI":"10.3389\/fphys.2019.00708","volume":"10","author":"NR Doudou","year":"2019","unstructured":"Doudou, N. R., Kampo, S., Liu, Y., Ahmmed, B., Zeng, D., Zheng, M., Mohamadou, A., Wen, Q. P., & Wang, S. (2019). Monitoring the early antiproliferative effect of the analgesic-antitumor peptide, BmK AGAP on breast cancer using intravoxel incoherent motion with a reduced distribution of four b-values. Frontiers in Physiology, 10, 708.","journal-title":"Frontiers in Physiology"},{"key":"1711_CR31","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3390\/molecules27072056","volume":"27","author":"A Rezaei","year":"2022","unstructured":"Rezaei, A., Asgari, S., Komijani, S., Sadat, S. N., Sabatier, J. M., Nasrabadi, D., Pooshang Bagheri, K., Shahbazzadeh, D., Akbari Eidgahi, M. R., De Waard, M., & Mirzahoseini, H. (2022). Discovery of leptulipin, a new anticancer protein from theiranian scorpion, hemiscorpius lepturus. Molecules, 27, 2056.","journal-title":"Molecules"},{"key":"1711_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12964-020-0530-4","volume":"18","author":"R Baghban","year":"2020","unstructured":"Baghban, R., Roshangar, L., Jahanban-Esfahlan, R., Seidi, K., Ebrahimi-Kalan, A., Jaymand, M., Kolahian, S., Javaheri, T., & Zare, P. (2020). Tumor microenvironment complexity and therapeutic implications at a glance. Cell Communication and Signaling : CCS, 18, 59.","journal-title":"Cell Communication and Signaling : CCS"},{"key":"1711_CR33","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s13346-016-0327-6","volume":"7","author":"JL Betker","year":"2017","unstructured":"Betker, J. L., & Anchordoquy, T. J. (2017). Assessing the effect of a nude mouse model on nanoparticle-mediated gene delivery. Drug Delivery and Translational Research, 7, 162\u2013167.","journal-title":"Drug Delivery and Translational Research"},{"key":"1711_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2021.07.015","volume":"134","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., & He, J. (2021). Tumor vasculature-targeting nanomedicines. Acta Biomaterialia, 134, 1\u201312.","journal-title":"Acta Biomaterialia"},{"key":"1711_CR35","doi-asserted-by":"publisher","first-page":"12223","DOI":"10.3390\/ijms252212223","volume":"25","author":"J Wang","year":"2024","unstructured":"Wang, J., He, Y., Hu, F., Hu, C., Sun, Y., Yang, K., & Yang, S. (2024). Metabolic reprogramming of immune cells in the tumor microenvironment. International Journal of Molecular Sciences, 25, 12223.","journal-title":"International Journal of Molecular Sciences"},{"key":"1711_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-017-0900-y","volume":"15","author":"DR Caswell","year":"2017","unstructured":"Caswell, D. R., & Swanton, C. (2017). The role of tumour heterogeneity and clonal cooperativity in metastasis, immune evasion and clinical outcome. BMC Medicine, 15, 133.","journal-title":"BMC Medicine"},{"key":"1711_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14050-z","volume":"11","author":"B Losic","year":"2020","unstructured":"Losic, B., Craig, A. J., Villacorta-Martin, C., Martins-Filho, S. N., Akers, N., Chen, X., Ahsen, M. E., von Felden, J., Labgaa, I., D\u2019Avola, D., Allette, K., Lira, S. A., Furtado, G. C., Garcia-Lezana, T., Restrepo, P., Stueck, A., Ward, S. C., Fiel, M. I., Hiotis, S. P., & Villanueva, A. (2020). Intratumoral heterogeneity and clonal evolution in liver cancer. Nature Communications, 11, 291.","journal-title":"Nature Communications"},{"key":"1711_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-021-01000-y","volume":"13","author":"C Suphavilai","year":"2021","unstructured":"Suphavilai, C., Chia, S., Sharma, A., Tu, L., Da Silva, R. P., Mongia, A., DasGupta, R., & Nagarajan, N. (2021). Predicting heterogeneity in clone-specific therapeutic vulnerabilities using single-cell transcriptomic signatures. Genome Medicine, 13, 189.","journal-title":"Genome Medicine"},{"key":"1711_CR39","doi-asserted-by":"publisher","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-05-0327","volume":"11","author":"SP Fraser","year":"2005","unstructured":"Fraser, S. P., Diss, J. K., Chioni, A. M., Mycielska, M. E., Pan, H., Yamaci, R. F., Pani, F., Siwy, Z., Krasowska, M., Grzywna, Z., Brackenbury, W. J., Theodorou, D., Koyut\u00fcrk, M., Kaya, H., Battaloglu, E., De Bella, M. T., Slade, M. J., Tolhurst, R., Palmieri, C., & Djamgoz, M. B. (2005). Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis. Clinical Cancer Research, 11, 5381\u20135389.","journal-title":"Clinical Cancer Research"},{"key":"1711_CR40","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1016\/j.acra.2010.07.009","volume":"17","author":"MA Jacobs","year":"2010","unstructured":"Jacobs, M. A., Stearns, V., Wolff, A. C., Macura, K., Argani, P., Khouri, N., Tsangaris, T., Barker, P. B., Davidson, N. E., Bhujwalla, Z. M., Bluemke, D. A., & Ouwerkerk, R. (2010). Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (23Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Academic Radiology, 17, 1477\u20131485.","journal-title":"Academic Radiology"},{"key":"1711_CR41","doi-asserted-by":"publisher","first-page":"639813","DOI":"10.3389\/fonc.2021.639813","volume":"11","author":"S Kampo","year":"2021","unstructured":"Kampo, S., Ahmmed, B., Zhou, T., Owusu, L., Anabah, T. W., Doudou, N. R., Kuugbee, E. D., Cui, Y., Lu, Z., Yan, Q., & Wen, Q. P. (2021). Corrigendum: Scorpion venom analgesic peptide, BmK AGAP inhibits stemness and epithelial-mesenchymal transition by down-regulating PTX3 in breast cancer. Frontiers in Oncology, 11, 639813.","journal-title":"Frontiers in Oncology"},{"key":"1711_CR42","doi-asserted-by":"publisher","first-page":"4707","DOI":"10.1038\/onc.2011.181","volume":"30","author":"X Fang","year":"2011","unstructured":"Fang, X., Cai, Y., Liu, J., Wang, Z., Wu, Q., Zhang, Z., Yang, C. J., Yuan, L., & Ouyang, G. (2011). Twist2 contributes to breast cancer progression by promoting an epithelial-mesenchymal transition and cancer stem-like cell self-renewal. Oncogene, 30, 4707\u20134720.","journal-title":"Oncogene"},{"key":"1711_CR43","doi-asserted-by":"publisher","first-page":"e48178","DOI":"10.1371\/journal.pone.0048178","volume":"7","author":"Y Mao","year":"2012","unstructured":"Mao, Y., Zhang, N., Xu, J., Ding, Z., Zong, R., & Liu, Z. (2012). Significance of heterogeneous Twist2 expression in human breast cancers. PLoS ONE, 7, e48178.","journal-title":"PLoS ONE"},{"key":"1711_CR44","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/bjc.2013.809","volume":"110","author":"G Chang","year":"2014","unstructured":"Chang, G., Wang, J., Zhang, H., Zhang, Y., Wang, C., Xu, H., Zhang, H., Lin, Y., Ma, L., Li, Q., & Pang, T. (2014). CD44 targets Na(+)\/H(+) exchanger 1 to mediate MDA-MB-231 cells\u2019 metastasis via the regulation of ERK1\/2. British Journal of Cancer, 110, 916\u2013927.","journal-title":"British Journal of Cancer"},{"key":"1711_CR45","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.bbrc.2018.05.018","volume":"501","author":"X Kong","year":"2018","unstructured":"Kong, X., Zhang, J., Li, J., Shao, J., & Fang, L. (2018). MiR-130a-3p inhibits migration and invasion by regulating RAB5B in human breast cancer stem cell-like cells. Biochemical and Biophysical Research Communications, 501, 486\u2013493.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1711_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-016-0287-7","volume":"23","author":"HT Tzeng","year":"2016","unstructured":"Tzeng, H. T., & Wang, Y. C. (2016). Rab-mediated vesicle trafficking in cancer. Journal of Biomedical Science, 23, 70.","journal-title":"Journal of Biomedical Science"},{"key":"1711_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10565-024-09866-5","volume":"40","author":"S Xu","year":"2024","unstructured":"Xu, S., Cao, B., Xuan, G., Xu, S., An, Z., Zhu, C., Li, L., & Tang, C. (2024). Function and regulation of Rab GTPases in cancers. Cell Biology and Toxicology, 40, 28.","journal-title":"Cell Biology and Toxicology"},{"key":"1711_CR48","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.3390\/cancers11081096","volume":"11","author":"F Guerra","year":"2019","unstructured":"Guerra, F., & Bucci, C. (2019). Role of the RAB7 protein in tumor progression and cisplatin chemoresistance. Cancers, 11, 1096.","journal-title":"Cancers"},{"key":"1711_CR49","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/ncb2165","volume":"13","author":"D Izawa","year":"2011","unstructured":"Izawa, D., & Pines, J. (2011). How APC\/C-Cdc20 changes its substrate specificity in mitosis. Nature Cell Biology, 13, 223\u2013233.","journal-title":"Nature Cell Biology"},{"key":"1711_CR50","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1080\/15384101.2019.1609830","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Han, T., Gan, M., Guo, M., Xie, C., Jin, J., Zhang, S., Wang, P., Cao, J., & Wang, J. B. (2019). A novel function of anaphase promoting complex subunit 10 in tumor progression in non-small cell lung cancer. Cell Cycle, 18, 1019\u20131032.","journal-title":"Cell Cycle"},{"key":"1711_CR51","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2006.10.006","volume":"250","author":"C Takahata","year":"2007","unstructured":"Takahata, C., Miyoshi, Y., Irahara, N., Taguchi, T., Tamaki, Y., & Noguchi, S. (2007). Demonstration of adiponectin receptors 1 and 2 mRNA expression in human breast cancer cells. Cancer Letters, 250, 229\u2013236.","journal-title":"Cancer Letters"},{"key":"1711_CR52","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3892\/or.2021.8246","volume":"47","author":"H Zhang","year":"2022","unstructured":"Zhang, H., Wang, J., Ge, Y., Ye, M., & Jin, X. (2022). Siah1 in cancer and nervous system diseases (Review). Oncology Reports, 47, 35.","journal-title":"Oncology Reports"},{"key":"1711_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-020-1124-3","volume":"20","author":"Z Xiao","year":"2020","unstructured":"Xiao, Z., Wei, Z., Deng, D., Zheng, Z., Zhao, Y., Jiang, S., Zhang, D., Zhang, L. J., Fan, M., Chen, S., Wang, S., Ding, Y., Ye, Y., & Jiao, H. (2020). Downregulation of Siah1 promotes colorectal cancer cell proliferation and migration by regulating AKT and YAP ubiquitylation and proteasome degradation. Cancer Cell International, 20, 50.","journal-title":"Cancer Cell International"},{"key":"1711_CR54","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.3892\/or.2014.3695","volume":"33","author":"H Shi","year":"2015","unstructured":"Shi, H., Zheng, B., Wu, Y., Tang, Y., Wang, L., Gao, Y., Gong, H., Du, J., & Yu, R. (2015). Ubiquitin ligase Siah1 promotes the migration and invasion of human glioma cells by regulating HIF-1\u03b1 signaling under hypoxia. Oncology Reports, 33, 1185\u20131190.","journal-title":"Oncology Reports"},{"key":"1711_CR55","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.3390\/cells13221870","volume":"13","author":"L Wang","year":"2024","unstructured":"Wang, L., Zhu, R., Wen, Z., Fan, H. S., Norwood-Jackson, T., Jathan, D., & Lee, H. J. (2024). Structural and functional insights into dishevelled-mediated Wnt signaling. Cells, 13, 1870.","journal-title":"Cells"},{"key":"1711_CR56","volume":"12","author":"Z Deng","year":"2024","unstructured":"Deng, Z., Sun, S., Zhou, N., Peng, Y., Cheng, L., Yu, X., Yuan, Y., Guo, M., Xu, M., Cheng, Y., Zhou, F., Li, N., Yang, Y., & Gu, C. (2024). PNPO-mediated oxidation of DVL3 promotes multiple myeloma malignancy and osteoclastogenesis by activating the Wnt\/\u03b2-catenin pathway. Advancement of Science, 12, e2407681.","journal-title":"Advancement of Science"},{"key":"1711_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04120-8","volume":"21","author":"Z Li","year":"2023","unstructured":"Li, Z., Yang, Z., Liu, W., Zhu, W., Yin, L., Han, Z., Xian, Y., Wen, J., Tang, H., Lin, X., Yang, Y., Wang, J., & Zhang, K. (2023). Disheveled3 enhanced EMT and cancer stem-like cells properties via Wnt\/\u03b2-catenin\/c-Myc\/SOX2 pathway in colorectal cancer. Journal of Translational Medicine, 21, 302.","journal-title":"Journal of Translational Medicine"},{"key":"1711_CR58","doi-asserted-by":"publisher","first-page":"dev146589","DOI":"10.1242\/dev.146589","volume":"145","author":"Z Steinhart","year":"2018","unstructured":"Steinhart, Z., & Angers, S. (2018). Wnt signaling in development and tissue homeostasis. Development, 145, dev146589.","journal-title":"Development"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-025-01711-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-025-01711-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T23:01:56Z","timestamp":1757199716000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-025-01711-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,13]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["1711"],"URL":"https:\/\/doi.org\/10.1007\/s12013-025-01711-8","relation":{},"ISSN":["1559-0283"],"issn-type":[{"type":"electronic","value":"1559-0283"}],"subject":[],"published":{"date-parts":[[2025,3,13]]},"assertion":[{"value":"25 February 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All applicable international, national, and\/or institutional guidelines for the care and use of animals were followed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}]}}